News

Survey: 69% support ACA’s contraceptive mandate


 

FROM JAMA

Public support for contraceptive coverage under the Affordable Care Act lags behind support for other preventive care benefits, according to a survey of 2,124 adults.

The survey, conducted by researchers at the University of Michigan in Ann Arbor and published April 22 in JAMA (doi:10.1001/jama.2014.4766]), comes as the Supreme Court debates whether to strike down the health reform law’s contraceptive mandate. A decision is expected in June.

©Tina Sbrigato/iStockphoto.com

Only 69% of respondents said that all health plans in the United States should be required to include coverage for birth control medications.

Overall, 69% of respondents said that all health plans in the United States should be required to include coverage for birth control medications. But support was higher for other preventive services mandated under the ACA, including mammograms and colonoscopies (85%), recommended vaccines (84%), screening tests for diabetes and high cholesterol (82%), and mental health care (77%).

Support for contraceptive coverage was highest among women, black and Hispanic respondents, parents with children living at home, and respondents who had health insurance. Education and income did not play a role, according to the researchers.

The study was funded by the Robert Wood Johnson Foundation Clinical Scholars program and the University of Michigan Health System. Dr. Matthew M. Davis, one of the study authors, reported that he serves as chief medical executive for the Michigan Department of Community Health. No other disclosures were reported.

mschneider@frontlinemedcom.com

On Twitter @maryellenny

Recommended Reading

FDA reviewing emergency contraception data in overweight women
MDedge Dermatology
Antidotes, detoxification agents, and pregnancy
MDedge Dermatology
Striking trends emerge in SLE joint replacement
MDedge Dermatology
Two doses of HPV vaccine effective against condyloma
MDedge Dermatology
VIDEO: Tips for treating acne in breastfeeding women
MDedge Dermatology
Chronic rhinosinusitis with nasal polyps more severe in women
MDedge Dermatology
FDA panel unanimously backs cobas HPV test as primary screening tool
MDedge Dermatology
U.S. tracking of HPV in cervical precancers confirms half due to 16/18
MDedge Dermatology
VIDEO: Don’t be afraid to treat acne in pregnant patients
MDedge Dermatology
Doctors reconstruct noses, create vaginas using engineered human tissue
MDedge Dermatology